SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma
Status:
Completed
Trial end date:
2000-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: SU5416 may stop the growth of Kaposi's sarcoma by stopping blood flow to the
tumor.
PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who have
AIDS-related Kaposi's sarcoma.